Cellectis (ALCLS) — Capital Reinvestment Ratio
Latest as of June 2024:
0.02x
Cellectis (ALCLS) has a Capital Reinvestment Ratio of 0.02x as of June 2024, meaning it reinvests 0% of its operating cash flow (€52.18 Million) in capital expenditures (€1.04 Million). See how much free cash does Cellectis generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
€52.18 Million
EUR
Capital Expenditures
€1.04 Million
EUR
Data as of
Jun 2024
Most recent filing
Cellectis Capital Reinvestment Ratio (2005–2024)
This chart tracks Cellectis's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Cellectis (2005–2024)
Year-by-year Capital Reinvestment Ratio for Cellectis from 2005 to 2024. For live market cap and broader valuation context, see ALCLS stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.17x | €22.99 Million | €3.84 Million | ▼ -86.1% |
| 2015 | 1.20x | €3.54 Million | €4.25 Million | ▲ +14068.8% |
| 2014 | 0.01x | €50.74 Million | €430.47K | ▼ -98.1% |
| 2008 | 0.44x | €1.78 Million | €790.71K | ▼ -50.8% |
| 2005 | 0.90x | €391.00K | €353.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow